drugset / Trial / NCT03104621
Efficacy and Tolerability of Preservative-free 0.0015% Tafluprost in Glaucoma Patients
RandomizedCrossoverQuadruple-blindTreatment
Summary
The aim of this work is to evaluate efficacy and tolerability of preservative containing 0.0015% tafluprost and preservative-free 0.0015% tafluprost. Both preservative containing and preservative-free 0.0015% tafluprost will reduce intraocular pressure significantly. In addition, preservative-free 0.0015% tafluprost might improve tolerability of glaucoma patients.
Timeline
- Start
- 2013-03
- Primary completion
- 2014-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BENZALKONIUM | Small molecule | 0.001 % | — |
| Subject | Tafluprost | Other / unclassified | 0.0015 % | Topical |